Laise R. Reis

Belo Horizonte, MG 30190002, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Next-generation intranasal influenza vaccines: mechanisms, platforms, and translational progress.

Next-generation intranasal influenza vaccines: mechanisms, platforms, and translational progress.

Journal: Frontiers in immunology

Published: February 11, 2026

Integrated analysis of humoral and memory B-cell responses reveals distinct immune landscapes shaped by influenza vaccine platforms.

Integrated analysis of humoral and memory B-cell responses reveals distinct immune landscapes shaped by influenza vaccine platforms.

Journal: NPJ vaccines

Published: August 18, 2025

Comparative analysis of cellular immune responses to four seasonal inactivated influenza vaccines in younger and older adults.

Comparative analysis of cellular immune responses to four seasonal inactivated influenza vaccines in younger and older adults.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: May 29, 2025

B-cell dynamics underlying poor response upon split-inactivated influenza virus vaccination.

B-cell dynamics underlying poor response upon split-inactivated influenza virus vaccination.

Journal: Frontiers in immunology

Published: August 16, 2024

Phenotypic Timeline Kinetics, Integrative Networks, and Performance of T- and B-Cell Subsets Associated with Distinct Clinical Outcome of Severe COVID-19 Patients.

Phenotypic Timeline Kinetics, Integrative Networks, and Performance of T- and B-Cell Subsets Associated with Distinct Clinical Outcome of Severe COVID-19 Patients.

Journal: Microorganisms

Published: May 29, 2024

Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults.

Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults.

Journal: Scientific reports

Published: October 11, 2023

Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.

Exploratory study of humoral and cellular immunity to 17DD Yellow Fever vaccination in children and adults residents of areas without circulation of Yellow Fever Virus.

Journal: Vaccine

Published: September 16, 2021

Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.

Corrigendum: Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.

Journal: Frontiers in immunology

Published: September 09, 2019

17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.

17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.

Journal: Emerging infectious diseases

Published: July 13, 2019

Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.

Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.

Journal: Frontiers in immunology

Published: June 26, 2019

Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.

Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.

Journal: Frontiers in immunology

Published: March 19, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026